 Protocol Title: A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1)
 Protocol Number: KTE-C19-101
 IND Number: 016278
 EudraCT Number: 2015-005007-86
 Clinical Study Sponsor: Kite Pharma, Inc. 2400 Broadway Santa Monica, CA 90404 United States of America
 Key Sponsor Contacts: PPD , Clinical Development Kite Pharma, Inc. 2 Roundwood Avenue Stockley Park Uxbridge, Middlesex Phone: PPD Email: PPD
 PPD Clinical Development Kite Pharma Inc. 2400 Broadway Santa Monica, CA 90404 Phone: PPD Email: PPD
 PPD Clinical Operations Kite Pharma, Inc. 2400 Broadway Santa Monica, CA 90404 Phone: PPD Email: PPD
 Version: 1.0 (Amendment # 8)
 Date: 11 February 2019
